Bioasis Technologies Inc. V.BTI

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.

TSXV:BTI - Post by User

Bioasis Technologies Inc. > Last day for tax-loss selling is today!

<< Previous

Bullboard Posts

Next >>

Comment by craighenryon Dec 28, 2022 3:32pm

85 Views

Post# 35194183

RE:RE:RE:RE:Last day for tax-loss selling is today!

Boomskid wrote:
I think pof is now just trying to annoy everybody. He knows that nobody is interested in reading this stuff he's posting over and over again.

But what can be said, anyway? In my opinion, there is nothing useful coming from the players in this deal. The agreements are so convoluted and the intentions of the players so obscure that Bioasis shareholders have no accurate means of assessing the deal or their chances of coming out of it with any skin left on themselves.

Distrust and hatred for Dr. Deborah Rathjen are palpable.

Most shareholders seem to be thinking that they must go along with all this, and so they will, but they have no confidence that there is a single living soul on this planet who cares a whit for their welfare.

JD